Prevalence of Antiphospholipid Antibody Syndrome Among Patients with Recurrent Pregnancy Loss: Impact of the Revised 2023 ACR/EULAR Antiphospholipid Syndrome Criteria

Marion Mercier, Alain Lescoat, Morgane Pierre-Jean, Erwan Dumontet, Maela Le Lous, Nicolas Belhomme · 2024

Read Prevalence of Antiphospholipid Antibody Syndrome Among Patients with Recurrent Pregnancy Loss: Impact of the Revised 2023 ACR/EULAR Antiphospholipid Syndrome Criteria by Marion Mercier, Alain Lescoat, Morgane Pierre-Jean, Erwan Dumontet, Maela Le Lous, Nicolas Belhomme (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11677686.txt.

Description

Marion Mercier and co-authors published a research paper in 2024 on how new, stricter rules for a clotting disorder change its counted share among women with repeated pregnancy loss. The disorder, antiphospholipid syndrome, is a standard suspect in such losses, and clinics screen for it widely. A 2023 rule update tightened what counts as a case.

The team reviewed 165 women fully assessed at a French university hospital over a decade. Under the old rules, about one in seven met the bar. Under the new rules, only two women qualified, leaving nearly all cases classed as unexplained. The authors ask whether the new bar now misses women who need care.

Catalog record

CREATORMarion Mercier, Alain Lescoat, Morgane Pierre-Jean, Erwan Dumontet, Maela Le Lous, Nicolas Belhomme
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11677686

Browse the full library · About the Tower of Babel